314 related articles for article (PubMed ID: 34377149)
1. Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management.
Sleutjes JAM; van Lennep JER; van der Woude CJ; de Vries AC
Therap Adv Gastroenterol; 2021; 14():17562848211032126. PubMed ID: 34377149
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation.
Weissman S; Sinh P; Mehta TI; Thaker RK; Derman A; Heiberger C; Qureshi N; Amrutiya V; Atoot A; Dave M; Tabibian JH
World J Gastrointest Pathophysiol; 2020 Aug; 11(5):104-113. PubMed ID: 32832194
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences.
Sinh P; Cross RK
Gastroenterol Hepatol (N Y); 2024 Apr; 20(4):204-215. PubMed ID: 38682122
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?
Bigeh A; Sanchez A; Maestas C; Gulati M
Trends Cardiovasc Med; 2020 Nov; 30(8):463-469. PubMed ID: 31653485
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease and thromboembolism.
Zezos P; Kouklakis G; Saibil F
World J Gastroenterol; 2014 Oct; 20(38):13863-78. PubMed ID: 25320522
[TBL] [Abstract][Full Text] [Related]
6. Risk of cardiovascular disease in inflammatory bowel disease.
Wu P; Jia F; Zhang B; Zhang P
Exp Ther Med; 2017 Feb; 13(2):395-400. PubMed ID: 28352306
[TBL] [Abstract][Full Text] [Related]
7. Standard and Extended Thromboprophylaxis in Patients with Inflammatory Bowel Disease: A Literature Review.
Harindranath S; Varghese J; Afzalpurkar S; Giri S
Euroasian J Hepatogastroenterol; 2023; 13(2):133-141. PubMed ID: 38222957
[TBL] [Abstract][Full Text] [Related]
8. Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.
Sbeit W; Kadah A; Shafrir A; Kalisky I; Mahamid M; Hazou W; Katz L; Mari A; Khoury T
Minerva Med; 2020 Dec; 111(6):560-565. PubMed ID: 32729705
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism in inflammatory bowel disease.
Cheng K; Faye AS
World J Gastroenterol; 2020 Mar; 26(12):1231-1241. PubMed ID: 32256013
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease.
Agrawal T; Acquah I; Dey AK; Glassner K; Abraham B; Blankstein R; Virani SS; Blaha MJ; Valero-Elizondo J; Mehta N; Quigley EM; Cainzos-Achirica M; Nasir K
Am J Prev Cardiol; 2021 Jun; 6():100171. PubMed ID: 34327497
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
Kappelman MD; Horvath-Puho E; Sandler RS; Rubin DT; Ullman TA; Pedersen L; Baron JA; Sørensen HT
Gut; 2011 Jul; 60(7):937-43. PubMed ID: 21339206
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview.
Gala D; Newsome T; Roberson N; Lee SM; Thekkanal M; Shah M; Kumar V; Bandaru P; Gayam V
Diseases; 2022 Sep; 10(4):. PubMed ID: 36278572
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease: JACC Review Topic of the Week.
Cainzos-Achirica M; Glassner K; Zawahir HS; Dey AK; Agrawal T; Quigley EMM; Abraham BP; Acquah I; Yahya T; Mehta NN; Nasir K
J Am Coll Cardiol; 2020 Dec; 76(24):2895-2905. PubMed ID: 33303079
[TBL] [Abstract][Full Text] [Related]
14. Venous Thromboembolism in Patients with Inflammatory Bowel Disease.
Dhaliwal G; Patrone MV; Bickston SJ
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202258
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular implications of inflammatory bowel disease: An updated review.
Bhardwaj A; Singh A; Midha V; Sood A; Wander GS; Mohan B; Batta A
World J Cardiol; 2023 Nov; 15(11):553-570. PubMed ID: 38058397
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation of venous thromboembolism in inflammatory bowel disease.
Papay P; Miehsler W; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Sobala A; Weltermann A; Eichinger S; Novacek G
J Crohns Colitis; 2013 Oct; 7(9):723-9. PubMed ID: 23127785
[TBL] [Abstract][Full Text] [Related]
17. Risk of cardiovascular disease in inflammatory bowel disease.
Andersen NN; Jess T
World J Gastrointest Pathophysiol; 2014 Aug; 5(3):359-65. PubMed ID: 25133036
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Venous Thromboembolism in Children and Young Adults With Inflammatory Bowel Disease.
McKie K; McLoughlin RJ; Hirsh MP; Cleary MA; Aidlen JT
J Surg Res; 2019 Nov; 243():173-179. PubMed ID: 31181463
[TBL] [Abstract][Full Text] [Related]
19. The oft-overlooked cardiovascular complications of inflammatory bowel disease.
Massironi S; Mulinacci G; Gallo C; Viganò C; Fichera M; Villatore A; Peretto G; Danese S
Expert Rev Clin Immunol; 2023 Apr; 19(4):375-391. PubMed ID: 36722283
[TBL] [Abstract][Full Text] [Related]
20. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
